Drug Pipeline

Tildrakizumab Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
0
Recruiting
2
Phase 3
2
Top Sponsors
Active Studies by Phase
Phase 4
1
Phase 3
1
Phase 2/3
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07352566 Utilization of a Microdevice for Psoriasis and Atopic Dermatitis Psoriasis Not Yet Recruiting
Phase 3
NCT06611163 A Study to Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects… Moderate to Severe Genital Psoriasis Active, Not Recruiting
Phase 2/3
NCT03997786 A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis Moderate-to-severe Chronic Plaque Psoriasis Active, Not Recruiting
Sponsors Running Tildrakizumab Trials
Sun Pharmaceutical Industries Limited (2) University of California, San Francisco (1)
Disease Areas
Psoriasis (3) Atopic Dermatitis (1)
Get alerts when Tildrakizumab trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free